インターベンショナル腫瘍学機器の世界市場レポート 2025年

インターベンショナル腫瘍学機器市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.3％で、33億4,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、低侵襲手術（MIS）への嗜好の高まり、研究開発費の増加、ヘルスケア支出の増加、新興経済諸国における高い潜在能力、がんや慢性疾患の有病率の増加などに起因すると考えられます。予測期間中の主な動向としては、先進的な画像誘導腫瘍学機器の開発に注力すること、革新的な機器を開発するためにAIを活用すること、腫瘍学手技の改善を可能にする新しい革新的な塞栓装置を開発すること、ロボット技術の活用に注力すること、製品開発と技術革新を加速するために他の企業や研究機関と協働することなどが挙げられます。

インターベンショナル腫瘍学機器市場の主要企業は、がん治療における診断精度や治療効果を向上させるため、組織量などの技術の進歩に注力しています。組織量とは、生検で得られる生体組織の量を指します。より多くの組織サンプルを採取することで、より綿密な分析が可能になり、診断精度が向上し、効果的な治療計画が立てやすくなります。例えば、2023年6月、米国の医療機器メーカーであるアルゴンメディカル社は、半自動生検装置スーパーコア・アドバンテージを発表しました。スーパーコア・アドバンテージは、競合製品よりも最大35%多く組織を採取できるため、正確な診断に必要な組織を十分に採取するために不可欠な、複数回の生検パスの必要性が低減されます。

がん罹患率の高さがインターベンショナル腫瘍学機器市場の成長を牽引すると予想されます。がんは、制御不能な細胞増殖を特徴とする疾患群であり、腫瘤や腫瘍の形成につながります。この高い有病率が、がんの診断、治療、管理に不可欠なインターベンショナル腫瘍学機器の需要を生み出し、早期発見、ステージング、モニタリングを可能にします。例えば、2024年7月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、オーストラリアにおけるがんの診断件数が2022年の160,570件から2023年には164,694件に増加したと報告し、前年比で大幅な増加を示しています。この動向は、がん罹患率の増加を裏付けており、市場におけるインターベンショナル腫瘍学機器の需要を裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界インターベンショナル腫瘍学機器PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のインターベンショナル腫瘍学機器市場：成長率分析
• 世界のインターベンショナル腫瘍学機器市場の実績：規模と成長, 2019-2024
• 世界のインターベンショナル腫瘍学機器市場の予測：規模と成長, 2024-2029, 2034F
• 世界インターベンショナル腫瘍学機器総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のインターベンショナル腫瘍学機器市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 塞栓デバイス
• アブレーション装置
• サポートデバイス
• 世界のインターベンショナル腫瘍学機器市場手順別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 熱腫瘍アブレーション
• 非熱的腫瘍アブレーション
• 経カテーテル動脈化学塞栓術（TACE）
• 経カテーテル動脈塞栓術（TARE）
• 選択的内部放射線療法（SIRT）
• 経カテーテル動脈塞栓術（TAE）
• 穏やかな塞栓術
• 世界のインターベンショナル腫瘍学機器市場がんの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝臓がん
• 腎臓がん
• 肺がん
• 骨がん
• その他のがんの種類
• 世界のインターベンショナル腫瘍学機器市場、塞栓デバイスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 塞栓剤
• 塞栓術用カテーテル
• 塞栓剤の送達システム
• 世界のインターベンショナル腫瘍学機器市場アブレーション装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高周波アブレーション装置
• マイクロ波アブレーション装置
• 凍結アブレーション装置
• レーザーアブレーション装置
• 世界のインターベンショナル腫瘍学機器市場、サポートデバイスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像誘導システム
• アクセスデバイス
• 流体管理システム

第7章 地域別・国別分析

• 世界のインターベンショナル腫瘍学機器市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のインターベンショナル腫瘍学機器市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• インターベンショナル腫瘍学機器市場：競合情勢
• インターベンショナル腫瘍学機器市場：企業プロファイル
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
  • Henlius Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Viant Medical
• AngioDynamics Inc.
• Pfizer
• Steris Applied Sterilization Technologies
• Dr.Reddys
• CapeRay
• Innovent Biologics
• Novartis AG
• Consonance
• ABLbio
• Adimmune
• Heraeus Medical
• Bioavlee
• Mediceena International
• Sinapi biomedical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• インターベンショナル腫瘍学機器市場2029：新たな機会を提供する国
• インターベンショナル腫瘍学機器市場2029：新たな機会を提供するセグメント
• インターベンショナル腫瘍学機器市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Interventional oncology devices are specialized medical tools and technologies designed for the minimally invasive diagnosis and treatment of cancer. These devices enable direct targeting of tumors, allowing for treatments such as ablation or embolization, which focus on destroying cancer cells while preserving nearby healthy tissue.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.39 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to aging population pool, an increase in cancer prevalence, increase in pharmaceutical R&D expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing older population, increasing preference towards minimally invasive surgeries (MIS), increasing research and development spending, a rise in healthcare expenditure, high potential in emerging economies and increasing prevalence of cancer and chronic diseases. Major trends in the forecast period include focusing on developing advanced image-guided oncology devices, utilizing ai to develop innovative devices, developing new, innovative embolic devices to enable improved oncology procedures, focusing on using robotics technology and collaborating with other companies and research institutes to accelerate product development and innovation.

Leading companies in the interventional oncology devices market are focusing on advancements in technologies, such as tissue volume, to improve diagnostic accuracy and treatment efficacy in cancer procedures. Tissue volume refers to the quantity of biological tissue obtained during a biopsy. Collecting larger tissue samples allows for more thorough analysis, enhancing diagnostic precision and aiding in effective treatment planning. For example, in June 2023, Argon Medical, a U.S.-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy device. The SuperCore Advantage collects up to 35% more tissue than competing products, reducing the need for multiple biopsy passes, which is essential for acquiring sufficient tissue for accurate diagnosis.

The high prevalence of cancer is expected to drive the growth of the interventional oncology devices market. Cancer is a group of diseases characterized by uncontrolled cell growth, leading to the formation of masses or tumors. This high prevalence creates a demand for interventional oncology devices, essential for diagnosing, treating, and managing cancer, enabling early detection, staging, and monitoring. For instance, in July 2024, the Australian Institute of Health and Welfare reported an increase in cancer diagnoses in Australia from 160,570 cases in 2022 to 164,694 in 2023, marking a significant year-over-year rise. This trend underscores the growing cancer prevalence, supporting the demand for interventional oncology devices in the market.

Companies in the interventional oncology devices market are increasingly incorporating robotics technology to enhance efficiency. Robotic systems integrate image-based planning and navigation, allowing accurate and efficient installation of instruments to specific body parts. In March 2022, the U.S. Food and Drug Administration approved Quantum Surgical's Epione interventional oncology robotics platform, showcasing the industry's commitment to technological advancements.

Major players in the interventional oncology devices market are focused on innovation, such as AI-powered digital pathology solutions, to enhance the accuracy of breast cancer diagnosis. Paige AI Inc., a U.S.-based biotechnology company, launched Paige Breast Lymph Node in March 2022, an AI-powered digital pathology solution improving the detection of breast cancer metastases in lymph node tissue. This technology offers AI-driven detection capabilities, a convenient heat map overlay, high sensitivity and specificity, seamless integration into existing workflows, user-friendliness, and robust security measures.

In August 2022, Boston Scientific Corporation acquired Obsidio Inc. for an undisclosed amount, aiming to expand its interventional oncology portfolio and strengthen its position in the growing market. Obsidio Inc., a U.S.-based medical device company, specializes in developing minimally invasive interventional oncology devices for treating liver cancer and other solid tumors.

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Embolization Devices, Ablation Devices, Support Devices
• 2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
• 3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
• Subsegments:
• 1) By Embolization Devices: Embolic Agents; Catheters For Embolization; Delivery Systems For Embolic Agents
• 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Laser Ablation Devices
• 3) By Support Devices: Imaging Guidance Systems; Access Devices; Fluid Management Systems
• Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; Henlius
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Devices Market Characteristics

3. Interventional Oncology Devices Market Trends And Strategies

4. Interventional Oncology Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Interventional Oncology Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Interventional Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Interventional Oncology Devices Market Growth Rate Analysis
• 5.4. Global Interventional Oncology Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Interventional Oncology Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Interventional Oncology Devices Total Addressable Market (TAM)

6. Interventional Oncology Devices Market Segmentation

• 6.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embolization Devices
• Ablation Devices
• Support Devices
• 6.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thermal Tumor Ablation
• Non-thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization (TACE)
• Transcatheter Arterial Radioembolization (TARE)
• Selective Internal Radiation Therapy (SIRT)
• Transcatheter Arterial Embolization (TAE)
• Bland Embolization
• 6.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liver Cancer
• Kidney Cancer
• Lung Cancer
• Bone Cancer
• Other Cancer Types
• 6.4. Global Interventional Oncology Devices Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embolic Agents
• Catheters For Embolization
• Delivery Systems For Embolic Agents
• 6.5. Global Interventional Oncology Devices Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation Devices
• Microwave Ablation Devices
• Cryoablation Devices
• Laser Ablation Devices
• 6.6. Global Interventional Oncology Devices Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Guidance Systems
• Access Devices
• Fluid Management Systems

7. Interventional Oncology Devices Market Regional And Country Analysis

• 7.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Devices Market

• 8.1. Asia-Pacific Interventional Oncology Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Devices Market

• 9.1. China Interventional Oncology Devices Market Overview
• 9.2. China Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Devices Market

• 10.1. India Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Devices Market

• 11.1. Japan Interventional Oncology Devices Market Overview
• 11.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Devices Market

• 12.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Devices Market

• 13.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Devices Market

• 14.1. South Korea Interventional Oncology Devices Market Overview
• 14.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Devices Market

• 15.1. Western Europe Interventional Oncology Devices Market Overview
• 15.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Devices Market

• 16.1. UK Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Devices Market

• 17.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Devices Market

• 18.1. France Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Devices Market

• 19.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Devices Market

• 20.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Devices Market

• 21.1. Eastern Europe Interventional Oncology Devices Market Overview
• 21.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Devices Market

• 22.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Devices Market

• 23.1. North America Interventional Oncology Devices Market Overview
• 23.2. North America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Devices Market

• 24.1. USA Interventional Oncology Devices Market Overview
• 24.2. USA Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Devices Market

• 25.1. Canada Interventional Oncology Devices Market Overview
• 25.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Devices Market

• 26.1. South America Interventional Oncology Devices Market Overview
• 26.2. South America Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Devices Market

• 27.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Devices Market

• 28.1. Middle East Interventional Oncology Devices Market Overview
• 28.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Devices Market

• 29.1. Africa Interventional Oncology Devices Market Overview
• 29.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

• 30.1. Interventional Oncology Devices Market Competitive Landscape
• 30.2. Interventional Oncology Devices Market Company Profiles
  • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Henlius Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Devices Market Other Major And Innovative Companies

• 31.1. Viant Medical
• 31.2. AngioDynamics Inc.
• 31.3. Pfizer
• 31.4. Steris Applied Sterilization Technologies
• 31.5. Dr.Reddys
• 31.6. CapeRay
• 31.7. Innovent Biologics
• 31.8. Novartis AG
• 31.9. Consonance
• 31.10. ABLbio
• 31.11. Adimmune
• 31.12. Heraeus Medical
• 31.13. Bioavlee
• 31.14. Mediceena International
• 31.15. Sinapi biomedical

32. Global Interventional Oncology Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

34. Recent Developments In The Interventional Oncology Devices Market

35. Interventional Oncology Devices Market High Potential Countries, Segments and Strategies

• 35.1 Interventional Oncology Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Interventional Oncology Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Interventional Oncology Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer